Experiences with
Imbruvica843 public posts
Want to take advantage of all our features? Just log in!
or
Frontline Ibrutinib/Venetoclax Elicits Durable Responses in CLL With Undetectable MRD
reported July 13, 2021 by Courtney Marabella
https://www.onclive.com/view/frontline-ibrutinib-venetoclax-elicits-durable-responses-in-cll-with-undetectable-mrd
Fixed-duration ibrutinib (Imbruvica) plus venetoclax (Venclexta) produced superior progression-free survival (PFS) when compared with chlorambucil